Retinal Vein Occlusion
Showing 51 - 75 of 116
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in New York (nepafenac 0.3%
Unknown status
- Neovascular Age-related Macular Degeneration
- +2 more
- nepafenac 0.3% suspension (Ilevro; Alcon, Fort Worth, TX)
- +2 more
-
New York, New YorkNew York Eye and Ear Infirmary
Apr 15, 2019
Prospective, Non-interventional, Multi-center Post-authorization
Completed
- Retinal Vein Occlusion
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Japan(unnamed)
Apr 9, 2019
Retinal Artery Occlusion, Retinal Vein Occlusion Trial (Remote ischemic conditioning)
Completed
- Retinal Artery Occlusion
- Retinal Vein Occlusion
- Remote ischemic conditioning
- (no location specified)
Apr 4, 2019
Retinal Vein Occlusion, Age Related Macular Degeneration Trial in Providencia (Ranibizumab Intravitreal injections)
Completed
- Retinal Vein Occlusion
- Age Related Macular Degeneration
- Ranibizumab Intravitreal injections
-
Providencia, Santiago DE Chile, ChileNovartis Investigative Site
Oct 10, 2018
Retinal Vein Occlusion Trial in Palo Alto (Nicotinic acid, Prednisolone acetate)
Completed
- Retinal Vein Occlusion
- Nicotinic acid
- Prednisolone acetate
-
Palo Alto, CaliforniaPalo Alto Medical Foundation Department of Ophthalmology
Dec 18, 2018
Retinal Vein Occlusion Trial in Rome
Unknown status
- Retinal Vein Occlusion
-
Rome, I, ItalySapienza University of Rome - Policlinico Umberto I Roma
Dec 11, 2018
Patients Treated for Macular Edema Due to Central Retinal Vein
Completed
- Retinal Vein Occlusion
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, Belgium(unnamed)
Sep 4, 2018
Healthy Subjects, Diabetic Retinopathy, Retinal Vein Occlusion Trial in Vienna (Dynamic Vessel Analyzer, Oxymap T1)
Completed
- Healthy Subjects
- +2 more
- Dynamic Vessel Analyzer
- Oxymap T1
-
Vienna, AustriaMedical University of Vienna
Aug 29, 2018
Neovascularization, Macular Degeneration, Diabetic Retinopathy Trial in Beirut (ziv-aflibercept)
Unknown status
- Neovascularization
- +7 more
-
Beirut, LebanonRafic Hariri University Hospital
Aug 27, 2018
Macular Edema, Cystoid, Retinal Vein Occlusion Trial in Madison (Standard Care, intravitreal triamcinolone injection)
Completed
- Macular Edema, Cystoid
- Retinal Vein Occlusion
- Standard Care
- intravitreal triamcinolone injection
-
Madison, WisconsinUniversity of Wisconsin
May 31, 2018
Visual Acuity & OCT Pattern of Macular Edema Secondary to RVO
Unknown status
- Retinal Vein Occlusion
- OCT
- (no location specified)
Apr 4, 2018
Retinal Vein Occlusion Trial in Tehran (injection bevacizumab, injection Combined Bevacizumab and Fasudil)
Unknown status
- Retinal Vein Occlusion
- injection bevacizumab
- injection Combined Bevacizumab and Fasudil
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Jan 4, 2018
Retinal Vein Occlusion, Posterior Vitreous Detachment Trial in Saint Louis (Ranibizumab)
Completed
- Retinal Vein Occlusion
- Posterior Vitreous Detachment
-
Saint Louis, MissouriBarnes Retina Institute
Oct 26, 2017
Retinal Vein Occlusion, Macular Edema Trial in Saint Louis (Intravitreal injection of bevacizumab, Intravitreal injection of
Completed
- Retinal Vein Occlusion
- Macular Edema
- Intravitreal injection of bevacizumab
- Intravitreal injection of ranibizumab (0.5 mg per dose)
-
Saint Louis, MissouriThe Retina Institute
Oct 26, 2017
Ischemia, Retinal Vein Occlusion, Pathologic Processes Trial in Houston (ranibizumab)
Terminated
- Ischemia
- +4 more
-
Houston, TexasRetina Consultants of Houston
May 2, 2017
Macular Edema, Retinal Vein Occlusion Trial (Sham injection, Ranibizumab injection 0.3 mg, Ranibizumab injection 0.5 mg)
Completed
- Macular Edema
- Retinal Vein Occlusion
- Sham injection
- +2 more
- (no location specified)
Jun 29, 2017
Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Philadelphia (Varying needle size with
Completed
- Age Related Macular Degeneration
- +2 more
- Varying needle size with intravitreal ranibizumab or aflibercept
-
Philadelphia, PennsylvaniaMid Atlantic Retina- Wills Eye Hospital
Jul 21, 2017
Macular Degeneration, Retinal Vein Occlusion, Diabetic Retinopathy Trial run by the NEI (Triamcinolone Acetonide)
Completed
- Macular Degeneration
- +2 more
- Triamcinolone Acetonide
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Macular Degeneration, Retinal Vein Occlusion Trial run by the NEI (Triamcinolone Acetonide (TAC-PF))
Completed
- Macular Degeneration
- Retinal Vein Occlusion
- Triamcinolone Acetonide (TAC-PF)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Retinal Vein Occlusion, Macular Edema Trial in Torrance (Ozurdex)
Completed
- Retinal Vein Occlusion
- Macular Edema
-
Torrance, CaliforniaRetina Macula Institute
Apr 26, 2017
Macular Edema, Retinal Vein Occlusion Trial (Ranibizumab injection 0.3 mg, Ranibizumab injection 0.5 mg, Sham injection)
Completed
- Macular Edema
- Retinal Vein Occlusion
- Ranibizumab injection 0.3 mg
- +2 more
- (no location specified)
Apr 4, 2017
Precision of the Microperimetry Function of the Spectral OCT/SLO
Completed
- Age-Related Macular Degeneration
- +8 more
-
Fort Lauderdale, Florida
- +2 more
Apr 3, 2017
Macular Edema, Retinal Vein Occlusion Trial in Sao Jose do Rio Preto (Dexamethasone drug delivery system (DDS-25))
Completed
- Macular Edema
- Retinal Vein Occlusion
- Dexamethasone drug delivery system (DDS-25)
-
Sao Jose do Rio Preto, SP, BrazilCentro de Pesquisa Rubens Siqueira
Jan 30, 2017